Preclinical CROs in Asia Pacific

8 contract research organizations in our directory list a site in Asia Pacific, across 3 countries. 4 report GLP capability and 4 report AAALAC accreditation. Compare services, species and accreditations below, and contact labs directly from their profiles.

8 CROs 4 GLP 4 AAALAC 3 countries

Preclinical research in Asia Pacific

Asia Pacific has become a major source of preclinical capacity. China and India host large integrated discovery and toxicology providers, Japan and South Korea have established GLP labs serving domestic and global sponsors, and Australia is often used for early clinical work that follows preclinical studies.

Regulatory status differs across the region: Japan, South Korea, Australia, New Zealand, India and Singapore adhere to the OECD Mutual Acceptance of Data system, while China does not fully adhere. Check inspection history and data acceptance for the regulator you plan to file with.

Among the CROs listed in Asia Pacific, the most common services are Toxicology, Surgery, Pharmacokinetics and Histology. The species they most often work with are Non-human Primate, Cynomolgus monkey and Rhesus monkey.

Showing 8 CROs with a site in Asia Pacific. Order rotates daily so no lab is permanently listed first.

Medicilon

Shanghai GLP AAALAC
Bioanalysis Toxicology Dog Mouse Non-human Primate Rabbit

NeuroBridge

Guangzhou Verified GLP AAALAC

NeuroBridge Biotechnology is a specialized preclinical research organization based in Guangzhou, China, focused on non-human primate (NHP) and pig disease models and exploratory non-GLP translational studies. We support…

AAV Biodistribution Acute Toxicity ADME Studies Behavioral Assessment Biodistribution Cynomolgus monkey Minipig Non-human Primate Rhesus monkey

WuXi AppTec

CN Verified GLP AAALAC

Global R&D services including discovery, DMPK, toxicology, bioanalysis, and manufacturing support.

Bioanalysis Histology Pharmacokinetics Surgery Toxicology Cynomolgus monkey Dog Mouse Pig

Questions to ask a CRO in Asia Pacific

  • Will the study run at the site in Asia Pacific, or could work be moved to another of your facilities?
  • How do you receive test article shipments, and what import permits or customs paperwork do you handle?
  • Can our team visit the facility before the study starts and during critical phases?
  • Which regulators and GLP monitoring authorities have inspected this site, and when?
  • What is your current lead time for our species at this site?

For a full checklist, see our CRO selection guide.